hexoprenaline has been researched along with Respiratory Distress Syndrome, Newborn in 3 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty white women with preterm labor between 24 and 34 weeks' gestation were treated for 48 hours with intravenous hexoprenaline." | 2.71 | Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor. ( Antonarakis, SE; Blouin, JL; Landau, R; Morales, MA; Smiley, RM, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Landau, R | 1 |
Morales, MA | 1 |
Antonarakis, SE | 1 |
Blouin, JL | 1 |
Smiley, RM | 1 |
Rush, RW | 1 |
Staudach, A | 1 |
1 trial available for hexoprenaline and Respiratory Distress Syndrome, Newborn
Article | Year |
---|---|
Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Alleles; Amino Acid Substituti | 2005 |
2 other studies available for hexoprenaline and Respiratory Distress Syndrome, Newborn
Article | Year |
---|---|
The management of preterm labour with intact membranes.
Topics: Adrenergic beta-Agonists; Calcium; Ethanol; Extraembryonic Membranes; Female; Fenoterol; Hexoprenali | 1980 |
[Tocolysis in imminent premature delivery: limits of indication--assessment of success--sources of error (author's transl)].
Topics: Adult; Female; Fetal Organ Maturity; Gestational Age; Hexoprenaline; Humans; Infant, Newborn; Lung; | 1981 |